Invention Grant
- Patent Title: Antisense compound for inducing immunological tolerance
- Patent Title (中): 用于诱导免疫耐受性的反义化合物
-
Application No.: US11941033Application Date: 2007-11-15
-
Publication No.: US08008469B2Publication Date: 2011-08-30
- Inventor: Dan V. Mourich , Hong M. Moulton , David J. Hinrichs , Patrick L. Iversen
- Applicant: Dan V. Mourich , Hong M. Moulton , David J. Hinrichs , Patrick L. Iversen
- Applicant Address: US OR Corvallis
- Assignee: AVI BioPharma Inc.
- Current Assignee: AVI BioPharma Inc.
- Current Assignee Address: US OR Corvallis
- Agency: Seed IP Law Group PLLC
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12Q1/68 ; A61K31/70

Abstract:
A method and conjugate for selectively killing antigen-activated T cells are disclosed. The conjugate is composed of a substantially uncharged antisense compound targeted against the human cFLIP protein, and a reverse TAT (rTAT) polypeptide coupled covalently to the antisense compound. The rTAT polypeptide is effective to produce selective uptake of the conjugate into antigen-activated T cells, relative to the uptake of the conjugate into non-activated T cells. The cFLIP antisense compound causes activation induced cell death (AICD) of activated lymphocytes. The method is useful in treating transplantation rejection and autoimmune conditions.
Public/Granted literature
- US20090111977A1 ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE Public/Granted day:2009-04-30
Information query